Nicole Lucas
Overview
    Explore the profile of Nicole Lucas including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              17
            
            
              Citations
              415
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Lakhotia R, Melani C, Dunleavy K, Pittaluga S, Desai S, Ahlman M, et al.
  
  
    Leuk Lymphoma
    . 2025 Feb;
          :1-12.
    
    PMID: 39899393
  
  
          Immune cells within the lymphoma tumor microenvironment promote immune evasion and are rational therapeutic targets. Alemtuzumab targets CD52 expressed on malignant B-cells and infiltrating nonmalignant T-cells. We evaluated the safety...
      
2.
        
    
    Chen D, Zigler C, Lin L, Lucas N, McFatrich M, Panagoulias J, et al.
  
  
    J Patient Rep Outcomes
    . 2024 May;
          8(1):50.
    
    PMID: 38743304
  
  
          Aims: Caregivers rate improved communication ability as one of the most desired outcomes for successful interventions for individuals with Angelman syndrome (AS). When measuring communication ability in clinical trials, the...
      
3.
        
    
    Coles T, McFatrich M, Ding H, Lucas N, Daniell E, Swaminathan A, et al.
  
  
    Patient
    . 2023 Dec;
          17(3):253-262.
    
    PMID: 38062222
  
  
          Objectives: This study aimed to describe quality of life for patients with chronic cough (CC) and identify meaningful attributes that affect patient treatment preferences to inform the design of a...
      
4.
        
    
    Burbank A, Lucas N, Lin L, Hernandez M, Reeve B
  
  
    J Allergy Clin Immunol Pract
    . 2023 Sep;
          11(12):3783-3785.
    
    PMID: 37678667
  
  
          No abstract available.
      
5.
        
    
    Reeve B, Lucas N, Chen D, McFatrich M, Jones H, Gordon K, et al.
  
  
    Eur J Paediatr Neurol
    . 2023 Aug;
          46:74-81.
    
    PMID: 37536121
  
  
          Purpose: The study goal was to validate the Observer-Reported Communication Ability (ORCA) measure for use with females with Rett Syndrome (RTT). Methods: Qualitative interviews, including concept elicitation and cognitive interviewing...
      
6.
        
    
    Zigler C, Lucas N, McFatrich M, Gordon K, Jones H, Berent A, et al.
  
  
    Am J Intellect Dev Disabil
    . 2023 Apr;
          128(3):185-203.
    
    PMID: 37104863
  
  
          Communication deficits have a substantial impact on quality of life for individuals with Angelman syndrome (AS) and their families, but limited qualitative work exists to support the necessary content of...
      
7.
        
    
    Zigler C, Lin L, McFatrich M, Lucas N, Gordon K, Jones H, et al.
  
  
    Am J Intellect Dev Disabil
    . 2023 Apr;
          128(3):204-218.
    
    PMID: 37104860
  
  
          There is a critical need for high-quality clinical outcome assessments to capture the important aspects of communication ability of individuals with Angelman syndrome (AS). To center the perspective of caregivers,...
      
8.
        
    
    Coles T, Lucas N, McFatrich M, Henke D, Ridgeway J, Behnken E, et al.
  
  
    Qual Life Res
    . 2022 Nov;
          32(3):841-852.
    
    PMID: 36322269
  
  
          Purpose: The purpose of this study is to evaluate potential gender-based differences in interpreting the Kansas City Cardiomyopathy Questionnaire (KCCQ-23) and to explore if there are aspects of health-related quality...
      
9.
        
    
    Lai C, Cole D, Steinberg S, Lucas N, Dombi E, Melani C, et al.
  
  
    Blood Adv
    . 2022 Jul;
          7(4):529-532.
    
    PMID: 35882475
  
  
          Aggressive lymphomas are curable with doxorubicin-based chemotherapy. In patients presenting with elevated serum bilirubin, doxorubicin is commonly dose reduced or delayed based on limited pharmacokinetic data. We evaluated plasma pharmacokinetics...
      
10.
        
    
    Coles T, Lucas N, Daniell E, Sullivan C, Wang K, Olsen J, et al.
  
  
    JMIR Form Res
    . 2022 Apr;
          6(4):e30877.
    
    PMID: 35394436
  
  
          Background: The Rosalynn Carter Institute for Caregivers (RCI) offers evidence-based interventions to promote caregivers' health and well-being. Trained coaches regularly meet with caregivers to offer education and instructions to improve...